Guest guest Posted October 2, 2001 Report Share Posted October 2, 2001 Duke Researchers Identify 10 Genes Believed To Protect Cancer Cells 2001 SEP 21 - (NewsRx.com) -- Cancer researchers at Duke University Medical Center have identified 10 genes believed to have significant roles in allowing cancerous tumors to thrive under oxygen-deficient conditions. The discovery is the first step in what could eventually lead to new treatments for some of the deadliest forms of cancer. Led by Dr. J. Riggins, an assistant professor of pathology and genetics at Duke, the team sifted through 24,504 genes expressed in the oxygen-deprived (hypoxic) cells in glioblastoma multiforme, which is a form of brain cancer. The researchers identified 10 genes, some of which can lead to the creation of new blood vessels that will connect to oxygen-starved tumors. The findings appear in the September 5, 2001 issue of the Journal of the National Cancer Institute. The research was done in collaboration with the Cancer Genome Anatomy Project in Washington, D.C., and funded by the National Cancer Institute and the S. McDonnell Foundation. " This is a crucial first step in understanding the complex interactions driving hypoxia response in tumors, " Riggins said. " The potential for exploiting these genes is tremendous in terms of turning off the angiogenesis (the formation of new blood vessels) of cancer and it may have significant use in other types of diseases as well, such as stroke and heart disease. This is a very early, very preliminary discovery. The gene discovery is the very first step in a very long road that will lead to something that has clinical use. " Previously, scientists thought angiogenesis was primarily influenced by a small set of genes including the vascular endothelial growth factor protein (VEGF), but Riggins suspects that the number of genes involved is significantly greater. " All of these genes are turned on to a higher level than what has classically been studied as a potent inducer of angiogenesis - VEGF. If any one of these genes turns out to be as potent or more potent than VEGF, then this is a fairly significant find. There is significant investment from the pharmaceutical industry to try and inhibit the function of this one particular gene, " he said. Other scientists had previously identified 10 genes that respond to hypoxia. The new Duke discovery adds another 10 to the mix of which three had never previously been identified, Riggins said. " These are completely novel genes that no one knows anything about, " he said. " We are working now to determine what their functions are beyond being induced by hypoxia. What specifically are they trying to do? Blood vessel growth? Are they trying to maintain pH in the tumor or are they trying to protect the cell in some other way? " One of the 10 genes is similar to a gene protein called angiopoietin-1, Riggins said. It has a structure that suggests it could be an angiogenesis promoting gene. __________________________________________________ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.